| Featured Articles |
 |
AIDS breakthrough as NHS rolls out new lifesaving medicine against mutant HIV
Mirror | August 16, 2026
|
|
Antimicrobial Resistance Communications Toolkit
CDC | Updated July 20, 2026
|
|
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
Merck | July 15, 2026
|
|
How a Drug With More Negative Than Positive Studies Won FDA Approval
MedPage Today | June 24, 2026
|
|
What To Know About the New HIV Medication Idvynso
The Body | May 7, 2026
|
|
Injectable HIV Treatment and PrEP
East Bay Getting to Zero | February 3, 2026
|
|
Some patients face hurdles getting HIV prevention drugs. Here's what to know
NPR | December 22, 2025
|
|
Updates to the ?Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV
HIV.gov | September 26, 2025
|
|
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Reuters | July 9, 2025
|
|
FDA approves twice-yearly capsid inhibitor for HIV prevention
Nature | July 8, 2025
|
| |
|
|
| News Updates |
|
Living With HIV and Other Conditions: How to Prevent Medication Interactions
Everyday Health | September 2, 2026
|
|
U.S. FDA Approves Gilead’s Bixlenvo™, a New Once-Daily Single Tablet Option for Virologically Suppressed Adults With HIV, Including Those...
GILEAD | August 27, 2026
|
|
Combination bnAbs Sustained Viral Suppression in Children After ART Interruption
IDSE | August 27, 2026
|
|
DoxyPEP Prevents Syphilis and Chlamydia in Real-World Studies
POZ | August 26, 2026
|
|
FDA Approves Dolutegravir for HIV Treatment in Newborns
Pharmacy Times | August 25, 2026
|
|
Some pharmacists can now apply for permits to provide HIV prevention pills without a doctor’s script
Spotlight | August 26, 2026
|
|
Global PrEP Use Remains Far Below Need, Analysis Finds
IDSE | August 25, 2026 |
|
Atazanavir/Ritonavir-Associated Erythema Multiforme in an HIV-1-Positive Patient
Cureus | August 22, 2026
|
|
NHS to roll out ‘life-saving’ meds to combat drug-resistant HIV
Pink News | August 17, 2026
|
|
Lenacapavir PrEP Still Effective With Longer Follow-Up
POZ | August 14, 2026
|
|
Once-weekly HIV pill shines in phase 3 trials
Healio | August 13, 2026
|
|
The drug lenacapavir is a mighty weapon against HIV. Its rollout gets mixed reviews
NPR | August 13, 2026
|
|
AIDS 2026: A new class of drugs could sharpen the body’s immune response to HIV
aidsmap | August 7, 2026
|
|
Big Pharma Fights the 340B Federal Drug Discount Program, Puts Profits Over Patients
POZ | August 7, 2026
|
|
AIDS 2026: Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions
MedPage Today | August 3, 2026
|
|
Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions
MedPageToday | August 3, 2026
|
|
The HIV shot that could change medicine is facing its biggest test: Getting to patients
Business Insider | July 31, 2026
|
|
Battle rages over access to new ‘miracle’ HIV drug
The Telegraph | July 31, 2026
|
|
AIDS 2026: Battle rages over access to new ‘miracle’ HIV drug
The Telegraph | July 31, 2026
|
| |
|
|
